NCT00427336View on ClinicalTrials.gov

Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Aplastic Anemia
Interventions
DRUG

Fludarabine

30 mg/m\^2 by vein daily over 30 minutes

DRUG

Cyclophosphamide

300 mg/m\^2 by vein daily over 2 hours

DRUG

Antithymocyte Globulin

3.75 mg/kg by vein daily over 4 hours

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00427336 - Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia | Biotech Hunter | Biotech Hunter